(Albany, US) DelveInsight has launched a new report on Psoriatic Arthritis Market
DelveInsight’s “Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Psoriatic Arthritis, historical and forecasted epidemiology as well as the Psoriatic Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Psoriatic Arthritis market report provides current treatment practices, emerging drugs, Psoriatic Arthritis market share of the individual therapies, current and forecasted Psoriatic Arthritis market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Psoriatic Arthritis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Psoriatic arthritis (PsA) is a chronic, progressive, inflammatory arthritis that affects joints and tendons. Some of the people with psoriasis (featured with red patches of skin topped with silvery scales) are diagnosed with psoriatic arthritis that may result in permanent joint damage and disability. They can affect any part of body, including fingertips and spine, Joint pain, stiffness, and swelling are the main signs and symptoms and can range from relatively mild to severe forms. In both psoriasis and psoriatic arthritis, disease flares may alternate with periods of remission. Of those with psoriatic arthritis, 40% have a family member with psoriasis or arthritis, suggesting heredity may play a role. Psoriatic arthritis can also result from an infection that activates the immune system. While psoriasis itself is not infectious, it might be triggered by a streptococcal throat infection, commonly known as strep throat.
View free sample page:- https://www.delveinsight.com/sample-request/psoriatic-arthritis-market
Psoriatic Arthritis Treatment
The DelveInsight Psoriatic Arthritis market report gives a thorough understanding of the Psoriatic Arthritis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. Because there are several features of psoriatic arthritis, there are different treatment options. Over the last decade, there has been a revolution of new therapies with biologics, leading to better control of the disease and its consequent complications. Several biologic disease-modifying antirheumatic drugs (bDMARDs) are approved for the treatment of PsA, including tumor necrosis factor (TNF)-α inhibitors (Adalimumab, Etanercept, Infliximab, Golimumab, and Certolizumab pegol), interleukin (IL) antagonists (Ustekinumab, Secukinumab, and Ixekizumab) and the immunosuppressant Abatacept. Additionally, Apremilast, an oral phosphodiesterase inhibitor, and Tofacitinib, an oral Janus kinase inhibitor, are also available under treatment options.
Psoriatic Arthritis Market
Over the past several years, an increased understanding of the pathophysiology of psoriasis and psoriatic arthritis (PsA) has led to the development of several new biologic therapies. Appropriate treatment selection and timing may slow, and even halt, the progression of psoriasis and PsA and decrease the economic burden. The current goals for treatment include minimizing disease activity, maintaining functional status, improving quality of life, and preventing or minimizing both disease- and treatment-related complications. The optimal choice of therapy may depend on disease severity, prognostic factors, prior treatment, comorbidities, access to therapy, and patient preferences.
Psoriatic Arthritis Report Scope
Download free sample page:- https://www.delveinsight.com/sample-request/psoriatic-arthritis-market
Table of content
1. Key Insights
2. Executive Summary of Psoriatic Arthritis
3. Competitive Intelligence Analysis for Psoriatic Arthritis
4. Psoriatic Arthritis: Market Overview at a Glance
5. Psoriatic Arthritis: Disease Background and Overview
6. Patient Journey
7. Psoriatic Arthritis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Psoriatic Arthritis Treatment
11. Marketed Products
12. Emerging Therapies
13. Psoriatic Arthritis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Psoriatic Arthritis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report?
Related Reports
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/